Industry Insight
Discovery Technology
Analytical Laboratory Technology
Delivery Systems
Ingredients, Formulation and Finishing
View our other publications with free access to extensive archives
  To view this article:
Existing subscribers please log in:
   Or select

Or become a subscriber

Click here to view
our current issue


The Directives Deadline

Mark Davison at rfxcel emphasises that companies must prepare for the onboarding process with the European Medicines Verification Organisation, especially as the deadline for the Falsified Medicines Directive comes closer.

By Mark Davison at rfxcel (July 2018)

Keywords: European Medicines Verification Organisation, Falsified Medicines Directive, technical onboarding

    View full article    |    Back to Biopharma section

Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPT © 2021 Innovations in Pharmaceutical Technology | Terms and Conditions | | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |